CHINA-SHANGHAI-NUCLEIC ACID TESTING SITES (CN)

CHINA-SHANGHAI-NUCLEIC ACID TESTING SITES (CN)

(220508) -- SHANGHAI, May 8, 2022 (Xinhua) -- A staff member takes a swab sample from a woman for nucleic acid test in Huangpu District, east China's Shanghai, May 8, 2022. Shanghai has set up fixed and mobile acid testing sites in areas such as residential communities, office spaces, business parks and in the vicinities of subway and other public transport stations in accordance with the epidemic situation. (Xinhua/Jin Liwang)

  • Product Code
  • ILEA000962946
  • Registered date
  • 2022/5/08 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 4000 × 2668 pixel
  • Resolution
  • dpi
  • Deployment size
  • 1.66(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    (ZhejiangPictorial)CHINA-ZHEJIANG-HANGZHOU-AUTONOMOUS DRIVING-MINIBUS (CN)

    (ZhejiangPictorial)CHINA-ZHEJIANG-HANGZHOU-AUTONOMOUS DRIVING-MINIBUS (CN)

    (240522) -- HANGZHOU, May 22, 2024 (Xinhua) -- A screen displays real-time road surface situation and operational information inside an autonomous driving minibus that runs on a road in Yuhang District, Hangzhou City, east China's Zhejiang Province, May 22, 2024. The autonomous driving bus route in Yuhang District is the first one of its kind powered by vehicle-road coordination technology in Hangzhou. This 5-kilometer bus line winds through schools, industrial parks, residential compounds and subway stations, free of charge for all citizens. Autonomous driving buses achieve holographic sensing of the road network through smart sensing devices such as high-definition cameras and radars along the roads. The vehicle-road coordination technology also effectively improves operational safety for the vehicles. That said, each of these buses still has a human supervisor, who would immediately take over the vehicle in case of emergency to further ensure passenger safety. (Xinhua/Huang Zongzhi)
      CHINA-GUIZHOU-GUIYANG-COVID-19-TESTING (CN)

      CHINA-GUIZHOU-GUIYANG-COVID-19-TESTING (CN)

      (220905) -- GUIYANG, Sept. 5, 2022 (Xinhua) -- A medical worker takes a swab sample from a resident for nucleic acid test at a community testing site for COVID-19 in Yunyan District of Guiyang, southwest China's Guizhou Province, Sept. 5, 2022. (Xinhua/Yang Wenbin)
        CHINA-TIANJIN-COVID-19-TEST (CN)

        CHINA-TIANJIN-COVID-19-TEST (CN)

        (220724) -- TIANJIN, July 24, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing at Heping District in Tianjin, north China, July 24, 2022. (Xinhua/Sun Fanyue)
          CHINA-TIANJIN-COVID-19-TEST (CN)

          CHINA-TIANJIN-COVID-19-TEST (CN)

          (220724) -- TIANJIN, July 24, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing at Heping District in Tianjin, north China, July 24, 2022. (Xinhua/Sun Fanyue)
            CHINA-TIANJIN-COVID-19-TEST (CN)

            CHINA-TIANJIN-COVID-19-TEST (CN)

            (220724) -- TIANJIN, July 24, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing at Heping District in Tianjin, north China, July 24, 2022. (Xinhua/Sun Fanyue)
              CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

              CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

              (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Bengshan District of Bengbu City, east China's Anhui Province, July 16, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
                CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

                CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

                (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Bengshan District of Bengbu City, east China's Anhui Province, July 16, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
                  CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

                  CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

                  (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Bengshan District of Bengbu City, east China's Anhui Province, July 16, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
                    CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

                    CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

                    (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Longzihu District of Bengbu City, east China's Anhui Province, July 17, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
                      CHINA-BEIJING-CHAOYANG-NUCLEIC ACID TESTING (CN)

                      CHINA-BEIJING-CHAOYANG-NUCLEIC ACID TESTING (CN)

                      (220611) -- BEIJING, June 11, 2022 (Xinhua) -- A medical worker takes a swab sample from a resident for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Ju Huanzong)